In 2006, Ikonisys received FDA approval for fastFIS amniocentesis an imaging application for the Ikoniscop automated identification of numerical aberrations of chromosomes offers common common birth defects. In addition, in early 2007, the company received FDA approval for oncoFIS bladder, a Ikoniscope application that helps in the initial diagnosis of bladder cancer potency synonyms .

To automate Additionally existing FISH tests allows the platform Cell Optics Ikonisys a stream of the next generation of diagnostic tests the the start of the detection of rare cells in a quick, efficient and economical manner. These signature tests include proprietary test specific reagent kits. Offers the ability to integrate the Cell Optics transfer of patient data transfer of patient data test data into a laboratory information systems – allows the creation of comprehensive health records – as well as the potential these novel tests to use as companion diagnostics that exploit a path more fully the promise of personalized medicine.

According to the Times to have some Obama consultant ‘ concern that people in the healthcare industry can attempt tackle the neighborhood meetings words. However, Cutter wrote the Obama transition team have no objection to the the participation of the health representatives from the industry at the event. She said: They are audio testing, adding. We are trying the people that to find Obamas goal of health reform shares, even if they contradict to the specific features Health insurance will be raise questions about Obama’s proposal to convene a new public health Schedules in direct competition with personal plans and to his plans, J Medicare Advantage plans pear Pear, Times, 12/17) to establish.